Join us on our noble mission to better brain health
Altoida AG
Incorporated
17.05.2016Headquarters
LuzernSupport
As a predictive digital biomarker company, Altoida, Inc. has developed technology using smart device sensors to measure cognition, function and motor skills. The innovation is based on three major pillars: (1) Active Digital Biomarkers, (2) Artificial Intelligence and (3) Augmented Reality. Altoida's Digital Neuro Signatures (DNS) is an FDA-cleared class II medical device, that collects data from the electronics sensors in the users device to analyze 748 proprietary digital biomarkers and provide an objective measurement of brain function across 11 neurocognitive domains and subdomains, (backed by DSM-5 criteria) and a novel Digital Neuro Signature score.
News
Altoida’s study unveils encouraging results for Alzheimer’s Disease assessment (startupticker.ch)
Positive clinical developments for three digital health startups (startupticker.ch)
Key executive hires for seven startups (startupticker.ch)
Applauses for Swiss Innovators (startupticker.ch)
"If not you, then who?" — Interview with Maria Luisa Fuchs of Startup@HSG at the University of St. Gallen (venturelab.swiss)
Altoida upsizes its Series A round to USD 20.3 million to advance its first-in-class AI-powered neurocognitive assessment platform (venturelab.swiss)
Additional $14 million for Altoida to advance its neurocognitive assessment platform (startupticker.ch)
New funding to accelerate Alzheimer’s disease diagnostic platform (startupticker.ch)
FDA Breakthrough Designation for Altoida's medtech neurology device (startupticker.ch)
Altoida secures funding and research partnership with Eisai Innovation (venturelab.swiss)
TOP 100 Swiss Startup Altoida Secures Investment From Hikma Ventures to Drive Better Clinical Outcomes For Brain Disease (venturelab.swiss)
Hikma Ventures invests in Altoida (startupticker.ch)
SHS Smarter Healthcare Booster Program reveals the winners (startupticker.ch)
Eight Swiss startups among the finalists of the Hello Tomorrow Challenge (startupticker.ch)
Le futur de la prévention pour le deuxième InnoPeaks (startupticker.ch)
Pascal H. Widmer from Alpana Ventures about the trends of early stage investments in Switzerland (venturelab.swiss)
Digital Health Startup Altoida Raises $6.3M Series A (startupticker.ch)
Videos and Presentations
Altoida Patient Training Video
Dementia precaution should become as normal as going to the dentist | Ioannis Tarnanas | TEDxZurich